Why Is Breast MRI so Controversial?
- 84 Downloads
Advances in dynamic contrast-enhanced (DCE) breast MRI over the past decade have led to significant improvements in the detection of early breast cancer and higher accuracy in the detection of multifocal and multicentric disease. This has resulted in the increased application of breast MRI in the diagnosis and management of breast cancer globally. Nonetheless, the true role of DCE breast MRI in the management of breast cancer patients remains controversial. This article discusses the strengths and limitations of DCE breast MRI by reviewing existing and emerging data from the past decade.
KeywordsBreast cancer or neoplasm Magnetic resonance imaging Outcomes Breast conserving surgery
No potential conflicts of interest relevant to this article have been reported.
Papers of particular interest, published recently have been highlighted as: • Of importance •• Of major importance
- 11.•• Lehman CD, Isaacs C, Schnall MD, et al.: Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007, 244:381–388. In this prospective screening study that included 171 high-risk women, the authors demonstrated that screening MRI detected more breast cancers than either mammography or ultrasound, although it resulted in a high biopsy rate. Ultrasound had the highest false-negative rate among the three modalities.Google Scholar
- 18.• Mann RM, Loo CE, Wobbes T, et al.: The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 2010, 119:415–422. This retrospective cohort study that included 267 women showed a significantly lower (9%) re-excision rate following breast conserving surgery for patients who underwent initial staging MRI as opposed to those who underwent only conventional imaging (mammography and ultrasound). Furthermore, preoperative MRI was not associated with an increased rate of initial mastectomies.Google Scholar
- 19.• Kuhl CK, Schrading S, Bieling HB, et al.: MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007, 11:485–492. In this prospective study, the authors investigated the sensitivity of mammography and breast MRI for the detection of DCIS and compared the biological profiles of DCIS detected by each modality. Forty-two percent of DCIS lesions detected by MRI were mammographically occult, whereas only 12% of the mammographically detected cases were occult by MRI. Biological profiles of detected DCIS lesions did not differ between the two groups.Google Scholar
- 21.Marcotte-Bloch C, Balu-Maestro C, Chamorey E: MRI for the size assessment of pure ductal carcinoma in situ (DCIS): A prospective study of 33 patients. Eur J Radiol 2009 [Epub ahead of print].Google Scholar
- 33.• Houssami N, Ciatto S, Macaskill P, et al.: Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26:3248–3258. This meta-analysis of 19 studies on MRI staging of the affected breast in women with primary breast cancer showed that MRI detected additional disease in 16% of women with breast cancer and led to more extensive surgery in an important proportion of women by identifying additional foci of cancer not evident on conventional imaging and clinical examination.Google Scholar
- 35.•• Solin LJ, Orel SG, Hwang WT, et al.: Relationship of breast magnetic resonance imaging to outcome after breast conserving therapy with radiation for women with early stage breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26:352–353. This single-center retrospective study of 756 patients with primary breast cancer scheduled for breast conserving therapy included 215 women who had breast MRI as part of their initial evaluation for primary breast cancer and 541 who did not. No benefit of MRI in reducing the local recurrence rate (extremely uncommon) and no difference in the incidence of contralateral breast cancer in the MRI and non-MRI groups was observed at 8 years.Google Scholar
- 41.• Lehman CD, Gatsonis C, Kuhl CK, et al.: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295–1303. The authors demonstrate that MRI can identify small cancers in the contralateral breast that are missed by mammography and clinical examination in 3.1% of the women at the time of the initial ipsilateral breast cancer diagnosis. MRI showed a high sensitivity (91%), specificity (88%), and negative-predictive value (99%) for the contralateral breast in patients with known ipsilateral breast cancer.Google Scholar
- 42.Renz DM, Böttcher J, Baltzer PA, et al.: The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer. Breast Cancer Res Treat. 2010 [Epub ahead of print].Google Scholar
- 43.• Brennan ME, Houssami N, Lord S, et al.: Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 2009, 27:5640–5649. A review of 22 studies reporting on contralateral MRI in women with newly diagnosed invasive breast cancer found MRI-only visible malignancies in 131 (4%) of 3253 women. The relatively high incremental cancer detection rate may reflect selection bias, and concerns regarding the potential harms of MRI screening leading to additional work-up and surgery without clear clinical benefit are raised, as MRI does not reliably differentiate benign from malignant lesions.Google Scholar
- 44.• Berg WA, Blume JD, Adams AM, et al.: Reasons women at elevated risk of breast cancer refuse Breast MR imaging screening: ACRIN 6666. Radiology 2010, 254:79–87. This study aims to determine the reasons for non-participation in a trial of supplemental MRI breast screening after mammography and ultrasound for women at increased risk of breast cancer who enrolled in the ACRIN 6666 ultrasound screening trial. Of 1215 women with analyzable data, only 57.9% of women agreed to participate in breast MRI screening. The primary reasons for non-participation in 512 women were claustrophobia (25.4%), time constraints (18.2%), and financial concerns (12.1%).Google Scholar
- 45.•• Turnbull L, Brown S, Harvey I, et al.: Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010, 375:563–571. This study was an open parallel trial with 45 participating centers in the United Kingdom that assessed the clinical efficacy of DCE MRI in 1623 women aged 18 years or older with primary breast cancer who were scheduled for wide local excision after triple assessment. The findings showed that the addition of MRI to conventional triple assessment did not significantly decrease the reoperation rate; 153 (19%) of 816 of the MRI group needed repeat surgery compared with 156 (19%) of 807 of the no-MRI group.Google Scholar
- 51.Jackson B, Scott-Conner C, Moulder J: Axillary metastasis from occult breast carcinoma: diagnosis and management. Am J Surg 1995, 61:431–434.Google Scholar